In 2023, CDC received reports of 89,000 Lyme disease cases but cautioned that many other cases were likely not reported. Surveillance efforts are difficult, many individuals are treated as outpatients, and diagnostic lab tests have limitations. CDC estimates that about 476,000 Americans may actually be diagnosed and treated for Lyme disease each year.
Listen to ASPET President, Dr. Carol Beck, share insight into the internal workings of ASPET, an overview of ASPET’s accomplishments this year and what’s coming up next, ASPET 2026, and bid farewell and welcome upcoming President Dr. Randy Hall.
As we approach the summer months, I’m pleased to turn our attention to a cornerstone of our community: connection. In the rapidly evolving landscape of pharmacology, staying connected—with peers, mentors, and collaborators—is essential. As you likely know, the ASPET Annual Meeting is perhaps the most impactful event we host each year to create connection, as we brought over 1,000 pharmacologists together in Portland, Oregon in April earlier this year.
Daniel Sitar, PHD, Ranked as Top Scholar, ASPET Welcomes New Members
Honoring ASPET members who have passed.
ASPET’s Government Affairs and Science Policy Department is making meaningful progress in strengthening the voice of the pharmacologist community in federal policy conversations.
A showcase of early-career scientists—what drives them and why pharmacology is important to them.
A Recap of the ASPET 2025 Annual Meeting. On behalf of the ASPET Council, the ASPET Program Committee, the ASPET 2025 Organizing Committee, and the ASPET staff, thank you for making the ASPET 2025 Annual Meeting a resounding success!
Listen to ASPET President, Dr. Carol Beck, discuss the ASPET SURF Summer program, the Norman Weiner Lecture, ASPET 2026 and more!
In an era where scientific research faces numerous challenges, your voice as a pharmacologist is more critical than ever. Advocating for pharmacology and science ensures that our work continues to receive the support and recognition it deserves. I strongly encourage all ASPET members to use any of the several avenues we have for members to engage in advocacy efforts.
